Prolonged twice‐daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client‐owned atopic dogs-Reference-Cited by-同舟云学术

Prolonged twice‐daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client‐owned atopic dogs

Published:2022-01-11 Issue:2 Volume:33 Page:149
ISSN:0959-4493
Container-title:Veterinary Dermatology
language:en
Short-container-title:Veterinary Dermatology

Author:

Denti Daria¹^ORCID,Caldin Marco²,Ventura Laura³,De Lucia Michela¹^ORCID

Affiliation:

1. Dermatology Unit, San Marco Veterinary Clinic and Laboratory Via dell’Industria 3 Veggiano 35030 Italy

2. Pathology Unit San Marco Veterinary Clinic and Laboratory Via dell’Industria 3 Veggiano 35030 Italy

3. Department of Statistical Sciences University of Padova Via Cesare Battisti 241 Padova 35121 Italy

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vde.13053

Reference29 articles.

1. Oclacitinib ( APOQUEL ® ) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy

2. European Medicines Agency website. Apoquel. Available at:https://www.ema.europa.eu/en/documents/assessment‐report/apoquel‐epar‐public‐assessment‐report_en.pdf. Accessed Nov 25 2020.

3. US Food and Drug Administration. website.Apoquel FOI. Available at: Available at:https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/902. Accessed May 2 2021.

4. Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

5. Age- and breed-matched retrospective cohort study of malignancies and benign skin masses in 660 dogs with allergic dermatitis treated long-term with versus without oclacitinib

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critically appraised topic: Benefits and risks of oclacitinib in treatment of allergic pruritus in dogs;Revue Vétérinaire Clinique;2024-01

2. Successful treatment of sebaceous adenitis with oclacitinib and low‐dose prednisolone in a dog;Veterinary Dermatology;2023-11-15

3. The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis;Veterinary Dermatology;2023-09-12

4. A randomised, double‐blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO‐524 in dogs with atopic dermatitis;Veterinary Dermatology;2023-07-23

5. Successful treatment of perianal fistulas in two dogs with oclacitinib;Veterinary Dermatology;2023-05-15